Idelvion IV 3500 (albutrepenonacog alpha), manufactured by CSL Behring, is an injectable recombinant factor IX albumin fusion protein indicated for the treatment and prophylaxis of bleeding in hemophilia B, available in a 3,500 IU vial for convenience. It has a YJ code of 6343448D5025 and a standard of 3,500 IU x 1 bottle (with dissolving solution).
Idelvion IV 3500
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →